Phenotyping calcification in vascular tissues using artificial intelligence

Mehdi Ramezanpour1, Anne M Robertson1, Yasutaka Tobe1

  • 1Department of Mechanical Engineering and Materials Science, University of Pittsburgh, PA, USA.

Arxiv
|February 5, 2024
PubMed

Insights

Vascular calcification contributes to cardiovascular events. This study introduces a new pipeline to classify calcification phenotypes, enabling better risk assessment for heart attack and stroke.

Area of Science:

  • Cardiovascular Research
  • Medical Imaging Analysis
  • Computational Pathology

Background:

  • Vascular calcification is a key factor in major adverse cardiovascular events (MACE), but its diverse phenotypes complicate clinical risk assessment.
  • Current methods, like coronary calcium scoring, have inconsistencies, highlighting the need for better tools to study calcification phenotypes.
  • Research into calcification's influence on risk is limited by the lack of high-throughput, objective, and non-destructive imaging analysis tools.

Approach:

  • Developed a novel classification system and semi-automated, non-destructive pipeline for phenotyping vascular calcification.
  • Integrated a deep-learning framework for segmenting lipid pools in micro-CT images and an unsupervised clustering method for categorizing calcification.
  • Demonstrated the pipeline's efficiency on five vascular specimens, phenotyping thousands of calcification particles across numerous images in under seven hours.

Key Points:

  • Achieved high accuracy (Dice scores of 0.96 for tissue, 0.87 for lipid pools) with minimal training data (13 images) despite tissue heterogeneity.
  • The pipeline effectively distinguishes diverse calcification phenotypes based on size, clustering, and topology.
  • The approach is efficient, objective, and non-destructive, facilitating large-scale studies.

Conclusions:

  • This work provides an efficient and comprehensive method for phenotyping vascular calcification.
  • Enables large-scale studies to identify more reliable indicators of cardiovascular event risk.
  • Aims to improve risk assessment for cardiovascular diseases, a leading cause of mortality.